It has been suggested that the defects in antigen processing observed in chronic myeloid leukaemia DCs may be related to the underlying cytoskeletal changes induced by the expression of the BCR-ABL fusion gene (Dong et al, 2003). The gene discussed is BCR; the disease is chronic myelogenous leukemia, BCR-ABL1 positive.